The management of low rectal cancer has undergone a remarkable transformation with the development of advanced imaging, neoadjuvant therapy, minimally invasive surgery, robotic platforms, and organ-preservation strategies. The modern objective is increasingly focused not only on removing cancer effectively but also on preserving sphincter function and improving long-term quality of life whenever this can be achieved without compromising oncological principles.

At WALS 2025, experts discussed the evolving role of sphincter salvage surgery and the techniques being used to manage selected patients with low and ultra-low rectal cancers. The conference highlighted the importance of individualized treatment, accurate staging, response assessment, minimally invasive surgery, functional outcomes, and multidisciplinary decision-making.

Changing Goals in Rectal Cancer Surgery

Historically, very low rectal cancers often presented a difficult surgical problem. When the tumor was close to the anal sphincter, achieving an adequate distal margin while preserving the sphincter was technically challenging. In patients requiring abdominoperineal resection, removal of the anus and rectum results in a permanent colostomy.

Modern treatment has created additional possibilities for selected patients. Improvements in pelvic imaging and surgical technique have made it possible to more accurately evaluate the relationship between the tumor and sphincter complex before surgery.

The goal of sphincter salvage is therefore not simply to avoid a colostomy. The broader objective is to achieve appropriate cancer control while preserving useful bowel function and minimizing treatment-related morbidity.

Importance of Accurate Patient Selection

Not every patient with low rectal cancer is a candidate for sphincter-preserving surgery.

Tumor height, depth of invasion, involvement of the external sphincter or levator muscles, mesorectal fascia status, lymph-node involvement, response to neoadjuvant therapy, baseline continence, and overall patient fitness all influence the decision.

High-resolution pelvic MRI has become an important component of preoperative evaluation. Endorectal ultrasound may also provide useful information in selected early-stage tumors. These investigations help the multidisciplinary team understand the anatomy before choosing the operative strategy.

Patient selection is particularly important because an operation designed to preserve the sphincter should not compromise the fundamental objective of cancer treatment.

Intersphincteric Resection as a Sphincter-Salvage Option

ISR is one of the key techniques used in selected ultra-low rectal cancers.

The operation involves dissection within the intersphincteric plane and, depending on tumor location and required margins, partial or more extensive removal of the internal anal sphincter. The external sphincter can potentially be preserved when it is not involved by the tumor.

The technique requires detailed knowledge of pelvic anatomy and careful assessment of the distal tumor margin. It also requires an understanding that preservation of the external sphincter does not necessarily result in completely normal continence.

The balance between oncological clearance and postoperative function is therefore central to the decision.

Robotic Assistance in Complex Pelvic Surgery

Robotic surgery has introduced additional technical capabilities into minimally invasive rectal surgery.

The deep pelvis can be difficult to access with conventional laparoscopic instruments. Robotic systems provide wristed instrumentation, magnified three-dimensional visualization, and improved instrument articulation, potentially assisting with precise dissection in confined anatomical spaces.

The WALS 2025 material discussed robotic-assisted ISR compared with laparoscopic ISR in early ultra-low rectal cancer and reported differences including reduced bleeding and fewer conversions to APR in the robotic group, while operative time was longer. Such findings illustrate both the potential benefits and trade-offs of advanced robotic approaches.

The technology, however, should complement rather than replace surgical judgment and anatomical expertise.

Neoadjuvant Therapy and Tumor Response

Neoadjuvant treatment has become an important component of contemporary rectal cancer care.

Treatment administered before surgery can reduce tumor burden and may alter the extent of disease. In selected patients, a major or complete clinical response can influence subsequent management.

This has created new opportunities for organ preservation. Instead of automatically proceeding to radical surgery in every patient, clinicians can increasingly consider response-adapted treatment strategies.

The WALS 2025 discussion emphasized the importance of assessing treatment response accurately when considering sphincter-preserving or non-operative approaches.

Watch-and-Wait: An Alternative to Immediate Surgery

The watch-and-wait approach has become one of the most discussed developments in organ-preserving rectal cancer treatment.

Patients who achieve a complete clinical response following neoadjuvant treatment may, in carefully selected circumstances, be managed without immediate radical surgery. Instead, they undergo intensive surveillance designed to detect local regrowth or other evidence of disease.

This approach can potentially preserve the rectum and avoid the functional consequences of radical surgery. However, it requires strict adherence to surveillance and careful clinical assessment.

It is therefore best understood as a highly structured treatment pathway rather than simply a decision not to operate.

Functional Outcomes After Sphincter Preservation

Preserving the sphincter anatomically is only one part of the treatment objective.

Following low anterior resection or ISR, patients may experience LARS, which can significantly affect daily life. Frequent bowel movements, urgency, clustering, incomplete evacuation, and varying degrees of incontinence may occur.

These functional outcomes should be discussed before surgery so that patients understand what sphincter preservation may realistically mean.

A successful treatment pathway should therefore include postoperative functional assessment and appropriate rehabilitation. Dietary modification, medication, pelvic-floor exercises, bowel-management programs, and specialist follow-up may all have roles depending on the individual patient.

Precision Through Minimally Invasive Techniques

The continuing evolution of minimally invasive colorectal surgery is providing surgeons with increasingly precise options.

Laparoscopy offers magnified visualization and access through small incisions. Robotic surgery adds articulated instruments and enhanced dexterity. Transanal approaches provide a direct route to selected distal rectal lesions and may assist with difficult pelvic dissection.

TEM and TAMIS can be useful for selected early rectal lesions, while TaTME has been developed as another approach for technically challenging mid- and low-rectal tumors. Each technique has specific indications, benefits, limitations, and learning requirements.

The key is selecting the right technique for the right patient rather than assuming that the newest technology is always the best option.

Quality of Life as a Surgical Endpoint

Modern rectal cancer surgery increasingly recognizes quality of life as an important clinical endpoint.

Avoiding a permanent stoma can be highly meaningful for many patients, but sphincter preservation should not be judged solely by stoma status. Continence, bowel frequency, urgency, sexual and urinary function, psychological well-being, return to normal activities, and long-term cancer control all contribute to the patient's experience.

This broader definition of success is helping shape the future of rectal cancer surgery.

Multidisciplinary Care and the Future

The complexity of low rectal cancer means that no single specialty can independently address every aspect of treatment. Surgeons, oncologists, radiologists, pathologists, gastroenterologists, specialist nurses, and rehabilitation teams can contribute to individualized treatment planning.

The WALS 2025 discussion reinforces the importance of multidisciplinary evaluation when deciding between radical surgery, sphincter-preserving procedures, local excision, and non-operative management.

Future advances are likely to focus on improving the prediction of treatment response, refining imaging, developing better biomarkers, expanding minimally invasive and robotic capabilities, and improving functional rehabilitation. Artificial intelligence may also contribute to more accurate interpretation of imaging and treatment-response assessment as the technology develops.

Ultimately, the future of sphincter salvage surgery is not defined by one operation. It is defined by the ability to integrate oncology, imaging, neoadjuvant treatment, precise surgery, functional preservation, and long-term surveillance into an individualized care pathway.

The WALS 2025 Conference provided an important platform for examining these developments and demonstrating how modern colorectal surgery is increasingly focused on preserving both cancer control and quality of life. For surgeons and medical professionals, understanding these evolving strategies is essential to providing patients with informed treatment choices and the most appropriate surgical approach for their individual disease.